ANI PHARMACEUTICALS, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ANI PHARMACEUTICALS, INC (ANIP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-07
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 0.00 shares.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 0.00 shares.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2014 was 120.00K shares, a 471.43% increase from fiscal 2013.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2013 was 21.00K shares.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2012 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 0.00 shares 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-08 | |||
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 0.00 shares 10-Q · filed 2026-08-07 | ||
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-08 | |||
| 2014-12-31 | 120.00K shares 10-K · filed 2015-02-23 | |||
| 2014-04-01 | 59.00K shares 10-Q · filed 2014-05-12 | |||
| 2013-12-31 | 21.00K shares 10-K · filed 2015-02-23 | |||
| 2012-12-31 | 0.00 shares 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |